NOTICE OF ANNUAL GENERAL MEETING Including Explanatory Notes and Proxy Form To be held: 10:00 am AEDT on Wednesday, 7 October 2026 Hamilton Locke, Level 10 161 Collins Street Melbourne Victoria 3000 -and- Virtually at this web address - https://meetings.lumiconnect.com/300-317-173-369 ...
2026 Notice of Annual General Meeting
Filed with ASX · · 56 pages · English
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Percheron Therapeutics Limited Corporate Presentation
- Percheron raises $2.3m to fully fund clinical trial in AML
- Proposed issue of securities - PER
- Initial Director's Interest Notice
- Transitional appointment of Executive Director
Later from Percheron Therapeutics
- Application for quotation of securities - PER
- Notice under S708A
- Dr Michael Baker Commences as CEO and MD
- Final Director's Interest Notice
- Annual General Meeting - Chair Address
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics